Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION, USP
| Report ID | 231738 |
| Drug Identification Number | 02245248 |
| Brand name | AMIODARONE HYDROCHLORIDE FOR INJECTION, USP |
| Common or Proper name | AMIODARONE HYDROCHLORIDE FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3 mL |
| ATC code | C01BD |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-07-30 |
| Actual start date | |
| Estimated end date | 2024-08-24 |
| Actual end date | 2024-08-29 |
| Shortage status | Resolved |
| Updated date | 2024-08-30 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Amiodarone Hydrochloride for Injection, USP 50 mg/mL MD Vial 3 mL effective July 30, 2024, until August 24, 2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-08-30 | English | Compare |
| v5 | 2024-08-29 | French | Compare |
| v4 | 2024-08-29 | English | Compare |
| v3 | 2024-07-31 | English | Compare |
| v2 | 2024-07-02 | French | Compare |
| v1 | 2024-07-02 | English | Compare |
Showing 1 to 6 of 6